NCT00645203View on ClinicalTrials.gov

Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

447

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

April 30, 2003

Conditions
Acute Otitis Media
Interventions
DRUG

cefdinir

cefdinir oral suspension, 25 mg/kg once daily for 10 days

Trial Locations (22)

4087

Panama City

11203

Brooklyn

14618

Rochester

14620

Rochester

15213

Pittsburgh

16508

Erie

27514

Chapel Hill

80218

Denver

84101

Beersheba

84113

Salt Lake City

85258

Scottsdale

93611

Clovis

93618

Dinuba

95630

Folsom

75390-9035

Dallas

Unknown

Providencia

Puente Alto, Santiago

Uruca

San José

Guatemala City

ZC 02

Santo Domingo

01011

Guatemala City

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY